Skip to content
DataLookout
Menu

NCT07930091

Molecular Biomarkers for Discriminating Lupus Nephritis in SLE

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: 1 to 2
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Discriminatory performance of the predefined molecular biomarker panel for distinguishing SLE patients with established LN from those without LN
Timeframe: baseline at day 1

Secondary (2)

Correlation of molecular biomarkers with SLE disease activity
Correlation of molecular biomarkers with SLICC/ACR-DI

Arms and interventions

Group 1: SLE with Lupus Nephritis

Patients with established systemic lupus erythematosus and established lupus nephritis.

Group 2: SLE without Lupus Nephritis

Patients with established systemic lupus erythematosus without lupus nephritis.

Diagnostic tests: predefined molecular biomarker panel